KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutrien (NTR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nutrien (NTR) over the last 10 years, with Q3 2025 value amounting to $514.0 million.

  • Nutrien's Cash & Equivalents fell 115.38% to $514.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.0 million, marking a year-over-year decrease of 115.38%. This contributed to the annual value of $741.0 million for FY2024, which is 1848.18% down from last year.
  • Nutrien's Cash & Equivalents amounted to $514.0 million in Q3 2025, which was down 115.38% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Nutrien's Cash & Equivalents peaked at $1.6 billion during Q2 2021, and registered a low of $315.0 million during Q3 2021.
  • For the 5-year period, Nutrien's Cash & Equivalents averaged around $771.3 million, with its median value being $711.0 million (2022).
  • As far as peak fluctuations go, Nutrien's Cash & Equivalents skyrocketed by 16978.02% in 2023, and later tumbled by 7135.1% in 2024.
  • Nutrien's Cash & Equivalents (Quarter) stood at $499.0 million in 2021, then soared by 80.56% to $901.0 million in 2022, then increased by 4.44% to $941.0 million in 2023, then decreased by 9.35% to $853.0 million in 2024, then crashed by 39.74% to $514.0 million in 2025.
  • Its Cash & Equivalents was $514.0 million in Q3 2025, compared to $1.2 billion in Q2 2025 and $828.0 million in Q1 2025.